Protocols to culture and harvest hepatic tumor organoids for metabolic assays

[1]  Hoi Yee Chu,et al.  A Combinatorial CRISPR–Cas9 Screen Identifies Ifenprodil as an Adjunct to Sorafenib for Liver Cancer Treatment , 2021, Cancer Research.

[2]  Joshua W K Ho,et al.  Lineage tracing and single-cell analysis reveal proliferative Prom1+ tumour-propagating cells and their dynamic cellular transition during liver cancer progression , 2021, Gut.

[3]  J. Yun,et al.  Loss of tyrosine catabolic enzyme HPD promotes glutamine anaplerosis through mTOR signaling in liver cancer. , 2021, Cell reports.

[4]  X. Wang,et al.  Understanding tumor cell heterogeneity and its implication for immunotherapy in liver cancer by single cell analysis. , 2020, Journal of hepatology.

[5]  C. Rice,et al.  Long-Term Expansion of Functional Mouse and Human Hepatocytes as 3D Organoids , 2018, Cell.

[6]  Jin Ding,et al.  Efficacy of annexin A3 blockade in sensitizing hepatocellular carcinoma to sorafenib and regorafenib. , 2018, Journal of hepatology.

[7]  Markus H. Heim,et al.  Organoid Models of Human Liver Cancers Derived from Tumor Needle Biopsies , 2018, Cell reports.

[8]  Bon-Kyoung Koo,et al.  Human Primary Liver Cancer -derived Organoid Cultures for disease modelling and drug screening , 2017, Nature Medicine.

[9]  Hans Clevers,et al.  Long-Term Culture of Genome-Stable Bipotent Stem Cells from Adult Human Liver , 2015, Cell.

[10]  I. Ng,et al.  Overriding Adaptive Resistance to Sorafenib Through Combination Therapy With Src Homology 2 Domain–Containing Phosphatase 2 Blockade in Hepatocellular Carcinoma , 2020, Hepatology.